ALZCUR.ST STO
AlzeCure Pharma AB
1W: -8.5%
1M: -15.7%
3M: -3.1%
YTD: +246.5%
1Y: +71.5%
3Y: +50.8%
5Y: -8.7%
kr 6.98 ($0.69)
+0.12 (+1.75%)
Weekly Expected Move ±5.7%
kr 6
kr 6
kr 7
kr 7
kr 8
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$35M
+1.5% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$35M
+1.9% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$19M
+685.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$78M | -$56M | -$37M | -$35M | -$48M |
| Depreciation & Amort. | $576K | $570K | $476K | $293K | $1M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $7M | -$44M | $40M | -$182K | $12M |
| Other Non-Cash Items | $145K | $203K | $0 | $0 | $0 |
| Operating Cash Flow | -$71M | -$100M | $3M | -$35M | -$35M |
| — Investing Activities — | |||||
| Capital Expenditures | -$54K | $0 | $0 | -$124K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $7K | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$54K | $0 | $7K | -$124K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$10M | $39K | -$7M | -$1M |
| Financing Cash Flow | $0 | $84M | $459K | $38M | $53M |
| Net Change in Cash | -$71M | -$16M | $4M | $2M | $19M |
| Cash End of Period | $42M | $26M | $29M | $31M | $50M |
| Free Cash Flow | -$71M | -$100M | $3M | -$35M | -$35M |